GlaxoSmithKline Pharmaceuticals reports 16% fall in Q4 net profit

18 Feb 2014 Evaluate

GlaxoSmithKline Pharmaceuticals has reported results for fourth quarter and year ended December 31, 2012.

The company has reported 15.61% fall in its net profit at Rs 116.88 crore for the quarter as compared to Rs 138.51 crore for the same quarter in the previous year. Total income of the company has decreased by 2.74% at Rs 685.04 crore for quarter under review as compared to Rs 704.34 crore for the quarter ended December 31, 2012.

For the year ended December 31, 2013, the company has posted a fall of 13.05% in its net profit at Rs 501.88 crore as compared to Rs 577.26 crore for the same period in the previous year.  Total income of the company has decreased by 2.71% at Rs 2747.12 crore for year under review as compared to Rs 2823.78 crore for the period ended December 31, 2012.

For the year ended December 31, 2013, on consolidated basis, the company has posted a fall of 14.27% in its net profit at Rs 481.67 crore as compared to Rs 561.88 crore for the same period in the previous year.  Total income from operation has decreased by 3.01% at Rs 2739.64 crore for year under review as compared to Rs 2824.85 crore for the period ended December 31, 2012.

Glaxosmithkline Phar Share Price

2464.90 -19.80 (-0.80%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×